Features

Features

Most significant clincal trials of 2024

From gene therapies to psychedelics and cancer vaccines to HIV pre-exposure prophylaxis (PrEP) drugs, 2024 has been a busy year…

Features

CTO Europe 2024: keep the burden of trials away from patients, say experts

Features

ADCs breach barriers to become mainstream cancer treatment

Features

WHO trial guidance goes beyond race and gender when tackling diversity

Features

Experts call for a shift from reactive to proactive clinical trial supply frameworks

Features

US reproductive laws could limit women’s participation in clinical trials

Features

Does Southeast Asia have a growing role in vaccine development?

Features

Prostate cancer: Three drug trials to watch

Features

How decentralisation can fill the gaps in Alzheimer’s research

Jenna Philpott and Irena Maragkou

Features

Preparing for DSCSA transition with tech-led compliance

Natasha Spencer-Jolliffe

Features

Adapting diabetes clinical trials to embrace underrepresented communities

Features

Mapping out strategies to overcome challenges in clinical research

Features

BIOSECURE Act: Companies turn to US manufacturers

Features

Obesity trial surge puts the focus back on decentralisation

Jenna Philpott and Irena Maragkou

Features

Cassava Sciences: Phase III trials storm ahead amid controversy

Features

Ushering in a new era of fit-for-purpose clinical endpoints for Rett syndrome

Features

Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial

Clinical Trials Arena Team

Features

Mpox: Three ongoing vaccine trials to watch

Features

Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial

Clinical Trials Arena Team

Features

Alzheimer’s heterogeneity necessitates diverse enrollment in clinical trials

Features

How the Covid-19 pandemic will help researchers with the mpox emergency

Features

Pipeline Moves: Investigator-led oncology cell therapy trial terminated

Clinical Trials Arena Team

Features

DMD clinical studies evolve with emphasis on building designs around relevant endpoints

Features

What is mpox and how big of a threat is it?

Features

Genetic testing in Parkinson’s disease patients: a standard of care imperative?

Features

Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes

Clinical Trials Arena Team

Features

Era of ADCs: Pharma companies innovate to stand out in a buzzing market

Akosua Mireku and Irena Maragkou

Features

How to build a future-ready lab to support the advancement of precision medicine

Features

Thermo Fisher Scientific: meeting the rising demand for ultra-cold storage

Features

How will cell & gene therapy manufacturing look in 10 years?

Features

Pipeline Moves: Novartis terminates Phase II ALS trial after benefit-risk worry

Clinical Trials Arena Team

Features

AIDS 24: Prioritise at risk populations for trials, testing and treatment

Features

Alzheimer’s: drug delivery and the blood brain barrier conundrum

Features

Inside the efforts to rescue a rare disease gene therapy

Features

Trials to watch: Four biologics concluding pivotal COPD trials

Features

Will anti-homosexuality bills in sub-Saharan Africa impede HIV research?

Abigail Beaney and Irena Maragkou

Features

Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated

Clinical Trials Arena Team

Features

Too much data: a burden or a blessing?

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close